VJVirtual | Immunotherapy clinical trials for mesothelioma to look out for

Hossein Borghaei, DO, MS, Fox Chase Cancer Center, Philadelphia, PA, shares immunotherapy clinical trials and treatments for mesothelioma to look out for, including the Phase III DREAM3R (NCT04334759) assessing durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.